Pramod K. Mistry, MBBS, PhD

Pramod Mistry practices at Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System.

Pramod Mistry's NPI, 1588648851, was assigned on December 1, 2005. Pramod Mistry graduated from Royal Free Hospital and University College London Medical School in 1983. Pramod Mistry holds Connecticut license 039656.

Pramod Mistry's primary practice is Greenwich Hospital, at 5 Perryridge Rd, Greenwich, CT 06830 in Fairfield County. The practice phone is (203) 863-3000.

Pramod Mistry's primary practice is Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System. Pramod Mistry is also affiliated with Tisch Hospital. The medical group on file is Yale Health. Dmand AI also links Pramod Mistry to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Pramod Mistry practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Pramod Mistry's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Pramod Mistry is licensed in Connecticut.

CMS data shows 47 Medicare services from Pramod Mistry across 2 procedure codes in 2024, for 63 Medicare patients. Medicare paid $3,017 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 63 Medicare patients who saw Pramod Mistry in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 32% are also on Medicaid. Their average risk score is 3.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Pramod Mistry's median patient age at 63, with 52% women.

In 2024, Pramod Mistry wrote 372 Medicare Part D claims for 33 patients. 15% of them were for generic drugs. CMS names the drug for 318 of them, across 6 drugs with 11 or more claims each, at $9,166,644 in total drug cost. In 2023, CMS named 300 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Pramod Mistry for performance year 2024, reported through an alternative payment model (APM). Pramod Mistry accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Pramod Mistry as offering telehealth.

Dmand AI links 100 papers to Pramod Mistry, published from 2010 to 2025. 2016 was the busiest year, with 10. The most frequent topics are Gaucher Disease, Glucosylceramidase and Enzyme Replacement Therapy. Pramod Mistry has published most often in Mol Genet Metab. Pramod Mistry's most frequent co-authors are Neal J. Weinreb, MD, Gregory M. Pastores, MD and Priya S. Kishnani.

Dmand AI links Pramod Mistry to 5 clinical trials. 1 is still active or recruiting. Conditions studied include Gaucher Disease, Sphingolipidoses and Niemann-Pick Disease, Type A. Genzyme, a Sanofi Company sponsors the most, 4. Open Payments lists research payments to Pramod Mistry that name 6 trials.

CMS Open Payments shows 578 general payments to Pramod Mistry from 3 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 36% of the total. Sanofi and Genzyme US Companies paid the most, $806,490. It also lists 56 research payments totaling $124,231 from 2017 to 2025, naming 6 clinical trials.

Pramod Mistry graduated from Royal Free Hospital and University College London Medical School in 1983.